KMT2C promoter methylation in...

Molecular Oncology 2020 / 11

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer

Mastoraki, Sofia, Balgkouranidou, Ioanna, Tsaroucha, Emily, Klinakis, Apostolos, Georgoulias, Vassilis, Lianidou, Evi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Molecular Oncology
DOI:
10.1002/1878-0261.12848
Date:
November, 2020
File:
PDF, 11.18 MB
2020
Conversion to is in progress
Conversion to is failed